Conventional models of one-drug-one-disease are changing fast. Genetic technologies are at the forefront, fueling new discoveries that link diseases, therapies, and patient responses. Thermo Fisher genetic analysis solutions are helping to rapidly drive connections for multi-therapeutic approaches to treat complex human diseases. Wherever you are in your journey from discovery to manufacturing, gain access to a breadth of genetic technologies that enables to you to keep up with the development pace of therapeutics, interventions, and vaccines.
The future of gene therapy
Now more than ever, we need to look to the future of aav gene therapy manufacturing. Hear from global CDMO Viralgen as they discuss new product innovations, their partnership with Thermo Fisher Scientific, and challenges faced in gene therapy manufacturing. Viralgen currently uses qPCR reagents in cell and gene therapy (CGT) manufacturing quality control.
Learn more ›
Clinical trials using genetic analysis are forecasted to be 3.5 months quicker in 2025
Stay ahead of the curve and download the e-book to learn:
- How genetic analysis is enabling more rapid and efficient clinical trials
- How integration of genetic analysis technologies is evolving in the pharma and biotech spaces
- How companies around the world are deploying genetic analysis to gain competitive advantage
Genetic solutions for novel therapeutics
Create advanced therapies, interventions, and vaccines for disease mechanisms that were previously considered difficult to target by leveraging our reliable genetic technologies to accelerate time to patient and improve safety and quality.
Genetic analysis technologies have become fundamental in discovering, designing, and confirming gene therapy approaches. Our comprehensive genetic portfolio and unrivaled services are here to support you at every step of the way, from proof-of-concept all the way to gene therapy manufacturing process.
Sequence confirmation is critical during mRNA therapeutic manufacturing, both during plasmid production and mRNA identity testing. Learn how our genetic technologies provide accurate and reproducible quality control (QC) for mRNA manufacturing to help ensure final product safety.
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.
Biopharma service and support solutions
Discover innovative support and services specific for biopharma. We can support you with remote tools, qualification services (IQ/OQ/PQ or IPV), computer system validation, and OEM expertise.
Explore more ›